Oncology Firm Pyxis Prices Upsized US$168 Million IPO
Preclinical oncology company Pyxis Oncology, Inc. (Nasdaq: PYXS) started publicly trading on the Nasdaq Global Select Market today under the
Read morePreclinical oncology company Pyxis Oncology, Inc. (Nasdaq: PYXS) started publicly trading on the Nasdaq Global Select Market today under the
Read more